Zobrazeno 1 - 10
of 26
pro vyhledávání: '"De Vries HM"'
Autor:
Pang KH; Department of Andrology, University College London Hospitals NHS Foundation Trust, London, UK; Division of Surgery and Interventional Science, University College London, London, UK., Fallara G; Division of Urology, IRCCS European Institute of Oncology, Milan, Italy., Lobo J; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal; Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center Raquel Seruca (P.CCC) & CI-IPOP@RISE (Health Research Network), Porto, Portugal; Department of Pathology and Molecular Immunology, ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal., Alnajjar HM; Department of Andrology, University College London Hospitals NHS Foundation Trust, London, UK; Division of Surgery and Interventional Science, University College London, London, UK., Sangar V; Department of Surgery, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK., von Stempel C; Division of Surgery and Interventional Science, University College London, London, UK; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Huang DY; Department of Clinical Radiology, King's College Hospital NHS Foundation Trust, London, UK; Department of Imaging Sciences, School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK., Parnham A; Department of Surgery, The Christie NHS Foundation Trust, Manchester, UK., Cazzaniga W; The Royal Marsden NHS Foundation Trust, London, UK., Giganti F; Division of Surgery and Interventional Science, University College London, London, UK; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Haider A; Department of Histopathology, University College London Hospitals NHS Foundation Trust, London, UK., Sachdeva A; Department of Surgery, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK., Albersen M; University Hospitals Leuven, Leuven, Belgium., Alifrangis C; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK; Department of Oncology, Barts Health NHS Trust, London, UK., Bandini M; Urological Research Institute, San Raffaele Scientific Institute, Milan, Italy., Castiglione F; Department of Urology, King's College Hospital NHS Foundation Trust, London, UK., De Vries HM; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Fankhauser C; Cantonal Hospital Lucerne, Lucerne, Switzerland; University of Zurich, Zurich, Switzerland., Heffernan Ho D; Department of Radiology, NHS Greater Glasgow and Clyde, Glasgow, Scotland., Nicol D; The Royal Marsden NHS Foundation Trust, London, UK., Shamash J; Department of Oncology, Barts Health NHS Trust, London, UK., Thomas A; University Hospitals Leuven, Leuven, Belgium., Walkden M; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Freeman A; Department of Histopathology, University College London Hospitals NHS Foundation Trust, London, UK., Muneer A; Department of Andrology, University College London Hospitals NHS Foundation Trust, London, UK; Division of Surgery and Interventional Science, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: asif.muneer@nhs.net.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.
Autor:
Elst L; Department of Urology, University Hospitals Leuven, Leuven, Belgium; Young Academic Urologists Working Group on Penile and Testis Cancer, Arnhem, The Netherlands., Vreeburg MTA; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., de Vries HM; Young Academic Urologists Working Group on Penile and Testis Cancer, Arnhem, The Netherlands; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Vandermaesen K; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Murphy T; Penile Cancer Centre, St. George's University Hospitals NHS Trust, London, UK., Churchill J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Fallara G; Young Academic Urologists Working Group on Penile and Testis Cancer, Arnhem, The Netherlands; Male Genital Cancer Centre, Department of Urology, NIHR Biomedical Research Centre University College London Hospitals, London, UK; Department of Urology, IRCCS European Institute of Oncology, Milan, Italy., Sanchez D; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Falcone M; Department of Urology, Molinette Hospital, University of Torino, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Garcia-Perdomo HA; Division of Urology/Urooncology, Department of Surgery, School of Medicine, Universidad del Valle, Cali, Colombia., Pettaway C; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hakenberg O; Department of Urology, University Medical Center Rostock, Rostock, Germany., Johnstone P; Departments of Radiation Oncology and Urology, Moffitt Cancer Center, Tampa, FL, USA., Spiess PE; Departments of Radiation Oncology and Urology, Moffitt Cancer Center, Tampa, FL, USA., Muneer A; Male Genital Cancer Centre, Department of Urology, NIHR Biomedical Research Centre University College London Hospitals, London, UK., Sangar V; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Parnham A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Ayres B; Penile Cancer Centre, St. George's University Hospitals NHS Trust, London, UK., Watkin N; Penile Cancer Centre, St. George's University Hospitals NHS Trust, London, UK., Brouwer OR; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Albersen M; Department of Urology, University Hospitals Leuven, Leuven, Belgium. Electronic address: maarten.albersen@uzleuven.be.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Jun; Vol. 7 (3), pp. 478-484. Date of Electronic Publication: 2023 Oct 07.
Autor:
Vreeburg MTA; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., de Vries HM; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van der Noort V; Department of Biometrics, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Horenblas S; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Rhijn BWG; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hendricksen K; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Graafland N; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Brouwer OR; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Publikováno v:
BJU international [BJU Int] 2024 May; Vol. 133 (5), pp. 596-603. Date of Electronic Publication: 2024 Feb 25.
Autor:
de Vries HM; Hielke M. de Vries, MD, Department of Medical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Urology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Oscar R. Brouwer, MD, PhD, Department of Urology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Eva Schaake, MD, PhD, Department of Radiation Therapy, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; and Michiel S. van der Heijden, MD, PhD, Department of Medical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Molecular Carcinogenesis, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Brouwer OR; Hielke M. de Vries, MD, Department of Medical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Urology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Oscar R. Brouwer, MD, PhD, Department of Urology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Eva Schaake, MD, PhD, Department of Radiation Therapy, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; and Michiel S. van der Heijden, MD, PhD, Department of Medical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Molecular Carcinogenesis, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Schaake E; Hielke M. de Vries, MD, Department of Medical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Urology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Oscar R. Brouwer, MD, PhD, Department of Urology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Eva Schaake, MD, PhD, Department of Radiation Therapy, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; and Michiel S. van der Heijden, MD, PhD, Department of Medical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Molecular Carcinogenesis, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van der Heijden MS; Hielke M. de Vries, MD, Department of Medical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Urology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Oscar R. Brouwer, MD, PhD, Department of Urology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Eva Schaake, MD, PhD, Department of Radiation Therapy, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; and Michiel S. van der Heijden, MD, PhD, Department of Medical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Molecular Carcinogenesis, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jan 10; Vol. 42 (2), pp. 243-244. Date of Electronic Publication: 2023 Nov 16.
Autor:
de Vries HM; Department of Internal Medicine, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Urology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Rafael TS; Department of Urology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Gil-Jimenez A; Department of Internal Medicine, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Molecular Carcinogenesis, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., de Feijter JM; Department of Internal Medicine, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Bekers E; Department of Pathology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van der Laan E; Department of Internal Medicine, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Lopez-Yurda M; Department of Biostatistics, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Hooijberg E; Department of Pathology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Broeks A; Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Peters D; Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Seignette IM; Department of Pathology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Pos FJ; Department of Radiation Therapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Horenblas S; Department of Urology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van Rhijn BWG; Department of Urology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Jordanova ES; Department of Urology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Brouwer OR; Department of Urology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Schaake E; Department of Radiation Therapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van der Heijden MS; Department of Internal Medicine, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Molecular Carcinogenesis, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Nov 01; Vol. 41 (31), pp. 4872-4880. Date of Electronic Publication: 2023 Jul 24.
Autor:
Ottenhof SR; Departments of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Vries HM; Departments of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Doodeman B; Departments of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands., Vrijenhoek GL; Departments of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Noort V; Departments of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Donswijk ML; Departments of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Feijter JM; Departments of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Schaake EE; Departments of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands., Horenblas S; Departments of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Brouwer OR; Departments of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: o.brouwer@nki.nl., van der Heijden MS; Departments of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Pos FJ; Departments of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Sep 01; Vol. 117 (1), pp. 139-147. Date of Electronic Publication: 2023 Apr 06.
Autor:
Youssef I; SUNY Downstate Medical Center Brooklyn New York USA.; Moffitt Cancer Center Tampa Florida USA., Elst L; University Hospitals Leuven Leuven Belgium., Watkin N; Department of Urology St George's University Hospitals NHS London UK., de Vries HM; The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital Amsterdam Netherlands., Brouwer O; The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital Amsterdam Netherlands., Protzel C; Department of Urology Helios Hospital Schwerin Schwerin Germany., Ayres B; Department of Urology St George's University Hospitals NHS London UK., Albersen M; University Hospitals Leuven Leuven Belgium., Spiess PE; Moffitt Cancer Center Tampa Florida USA., Johnstone PAS; Moffitt Cancer Center Tampa Florida USA.
Publikováno v:
BJUI compass [BJUI Compass] 2023 Aug 30; Vol. 5 (1), pp. 166-169. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2024).
Autor:
de Vries HM; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Ottenhof SR; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Rafael TS; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Werkhoven E; Department of Biostatistics, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Pos FJ; Department of Radiation therapy, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Rhijn BWG; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Moonen LMF; Department of Radiation therapy, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Graafland N; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., de Feijter JM; Department of Internal Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Schaake EE; Department of Radiation therapy, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Horenblas S; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Brouwer OR; Department of Urology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2022 Dec 15; Vol. 47, pp. 29-35. Date of Electronic Publication: 2022 Dec 15 (Print Publication: 2023).
Autor:
Wever L; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., de Vries HM; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands., Dell'Oglio P; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Donswijk ML; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Sikorska K; Department of Biometrics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Leeuwen FWB; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands., Horenblas S; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Brouwer OR; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands.
Publikováno v:
BJU international [BJU Int] 2022 Oct; Vol. 130 (4), pp. 486-495. Date of Electronic Publication: 2022 Mar 17.
Autor:
Fankhauser CD; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. cdfankhauser@gmail.com.; Department of Urology, Luzerner Kantonsspital, University of Lucerne, Lucerne, Switzerland. cdfankhauser@gmail.com.; University of Zurich, Zurich, Switzerland. cdfankhauser@gmail.com.; Luzerner Kantonsspital, Luzern, Switzerland. cdfankhauser@gmail.com., de Vries HM; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., Roussel E; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Jakobsen JK; Department of Urology, Aarhus University Hospital, Aarhus, Denmark., Issa A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Lee EWC; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Schifano N; NIHR Biomedical Research Centre, University College London Hospital, London, UK.; Department of Urology, University College London Hospital, London, UK.; Division of Surgery and Interventional Science, UCL, London, UK., Alnajjar H; NIHR Biomedical Research Centre, University College London Hospital, London, UK.; Department of Urology, University College London Hospital, London, UK.; Division of Surgery and Interventional Science, UCL, London, UK., Castiglione F; NIHR Biomedical Research Centre, University College London Hospital, London, UK.; Department of Urology, University College London Hospital, London, UK.; Division of Surgery and Interventional Science, UCL, London, UK., Antonelli L; Department of Urology, Luzerner Kantonsspital, University of Lucerne, Lucerne, Switzerland.; Department of Urology, Policlinico Umberto I, Rome, Italy., Oliveira P; Department of Pathology, The Christie NHS Foundation Trust, Manchester, UK., Lau M; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Parnham A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Albersen M; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Watkin NA; Department of Urology, St George's Hospital, London, UK., Muneer A; NIHR Biomedical Research Centre, University College London Hospital, London, UK.; Department of Urology, University College London Hospital, London, UK.; Division of Surgery and Interventional Science, UCL, London, UK., Ayres BE; Department of Urology, St George's Hospital, London, UK., Brouwer OR; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., Sangar V; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Manchester Academic Health Sciences Centre, Manchester, UK.
Publikováno v:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2022 Sep; Vol. 148 (9), pp. 2231-2234. Date of Electronic Publication: 2022 Apr 12.